PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 15459276

Medication errors and confusion over labelling.

Roxane J Hillier·Simon P Kelly
View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Drug LabelingHumansMedication ErrorsCommentLetter

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Roxane J Hillier, Simon P Kelly. 2004. Medication errors and confusion over labelling.. https://doi.org/10.1177/0141076809701028

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of monograph for OTC nasal decongestant drug products. Final rule.

The Food and Drug Administration (FDA) is issuing a final rule to amend the final monograph (FM) for over-the-counter (OTC) nasal decongestant drug products (drug products used to relieve nasal congestion due to a cold, hay fever, or other upper respiratory allergies) to add phenylephrine bitartrate (PEB), both individually and in combination drug products in an effervescent dosage form, as generally recognized as safe and effective (GRASE). An effervescent dosage form is intended to be dissolved in water before taking by mouth. This final rule is part of FDA's ongoing review of OTC drug products.

Drug Labeling↗